18 AI Use Cases Across the Drug Development Lifecycle

Most pharma AI pilots die in validation review, while your teams hand assemble evidence for INDs, TMFs, deviations and dossiers. These 18 production-grade use cases map governed AI to all six stages of drug development on the Progress^® Data Platform, with outcomes you can defend in inspection.

Talk to a Life Sciences Specialist

Find Your Use Case

Trusted by

Member of

73%

More correct answers from the baseline semantic graph.

A Pharmaceutical Leader

40%

Less time spent searching for research data.

Syngenta

$2.67B

Average cost to develop one drug asset with every recovered hour compounding.

Deloitte 2025

Why Now

The 2026 Edge Is How Deeply AI Is Woven into Validated Workflows

Most life science AI initiatives stall at the pilot stage, with impressive demos that cannot survive validation, inspection or scale.

The organizations pulling ahead take a validation-first approach: AI grounded in trusted context, constrained by business rules and traceable to source evidence. That is what turns AI from a science project into operating capacity across the lifecycle.

The short version: 18 use cases with six lifecycle stages and one governed platform pattern with trusted context, semantic meaning and governed agentic AI—from research knowledge graphs to agentic market-access copilots.

From Pilots to Production

Four Steps from First Use Case to Lifecycle Scale

Start with One Use Case

Pick the Evidence-Heavy Bottleneck That Hurts Most

Four common first projects are flagged in the catalog

Prove It in Validation

Stand It Up Beside Your Validated Systems

With lineage, citations and human approval intact

Reuse the Foundation

The Ontology, Rules and Governance You Built

Become assets that every next use case inherits

Scale Across the Lifecycle

Extend Stage by Stage

Each new use case costs less than the one before it

The Catalog

Find Where Governed AI Pays Off First in Your Pipeline

Pick your lifecycle stage to see who owns it and the problems costing you most. Open any use case for the challenge, the platform pattern and the expected outcomes.

01 Research & Development R&D Leadership

Accelerate discovery

CSO, Head of R&D, Heads of Discovery and Translational

You own scientific priorities and the pipeline. Governed knowledge graphs and automated evidence packs mean less rediscovery, faster IND-ready evidence and AI answers your scientists can verify.

Use Cases

automation

Cut recurring R&D surveillance cost by an estimated $1.5 - $2.0M a year by automating literature monitoring, competitive intelligence and target triage.

Challenge solved: Knowledge & evidence no longer scattered across documents.

WHO RUNS IT

R&D IT, scientific informatics, ontology and knowledge management, with the CIO and Chief AI Officer

Stage: Research & Development

THE CHALLENGE

Scientific knowledge is duplicated across teams and critical signals get missed. Literature monitoring, competitive intelligence and target triage are manual, fragmented and repeated in every therapeutic area.

THE PLATFORM PATTERN

The semantic layer acts as the enterprise ontology authority by standardizing targets, pathways, competitors and programs, while the trusted context hub unifies them into one governed, queryable graph across Discovery, Preclinical and Early Development stages. Optional governed generative AI (GenAI) runs on curated knowledge with low hallucination risk, because every answer is grounded in validated, traceable metadata.

EXPECTED OUTCOMES

Retires duplicated third-party monitoring services
Cuts manual curation effort by 25 - 40%
Speeds up portfolio decisions with prioritized digests
Future-readies R&D intelligence without net-new headcount

automation common first project

Reduce manual evidence-pack effort per IND by 40 – 60%, trimming an estimated $12 – $18K of prep cost from every program.

Challenges solved: Knowledge & evidence no longer scattered across documents. More efficiency and lower cost for submissions & approvals.

WHO RUNS IT

R&D IT, scientific informatics, ontology & knowledge management, with the CIO and Chief AI Officer

Stage: Research & Development

THE CHALLENGE

Assembling IND-ready evidence, including targets, efficacy, tox and biomarkers, is manual document hunting and duplicative writing, slow and error-prone in every program.

THE PLATFORM PATTERN

Ontology-driven natural language processing (NLP) extracts and normalizes evidence; the platform then stores it as a governed, reusable evidence hub. AI assembles structured packs and flags gaps with full traceability back to their source so outputs stay defensible and inspection-ready, and every program starts from structured facts instead of a blank page.

EXPECTED OUTCOMES

Cuts 40 – 60% of manual effort per IND
Prevents redundant internal or outsourced studies
Speeds up go/no-go decisions with structured evidence
Delivers clean handoffs into Clinical and Regulatory phases

agentic ai

Replace manual coordination across preclinical, tox, translational and regulatory teams with governed agents that draft, check and route evidence packs.

Challenge solved: AI pilots reach production safely.

WHO RUNS IT

Chief AI Officer, R&D IT, enterprise architecture, Program Operations

Stage: Research & Development

THE CHALLENGE

Cross-functional "glue work," including coordinating evidence drafting, completeness checks and task routing across Preclinical, Tox, Translational, Clinical and Regulatory, consumes scarce Ph.D./M.D. and Program Ops time.

THE PLATFORM PATTERN

The semantic layer governs language and extracts traceable facts; the trusted context hub then consolidates reusable knowledge and agentic RAG orchestrates the workflow. Agents draft packs, run completeness checks and route tasks with human approval gates and full citations, demonstrating the shift from AI insight to AI execution.

EXPECTED OUTCOMES

Cuts 35 - 50% of pack-assembly time
Reduces cross-functional delays and handoff gaps
Avoids CRO and vendor rework
Standardizes citation-backed evidence packs

02 Clinical Clinical Development & Operations

Scale trial intelligence

CMO, VP Clinical Development, VP Clinical Operations, COO

You own trial timelines, site performance and safety. Automated case intake, TMF evidence automation and an action orchestrator cut backlogs without adding another disconnected system.

Use Cases

automation common first project

Automate Individual Case Safety Report (ICSR) intake, narrative normalization and MedDRA/WHO-DD coding, which translates into an estimated ~$490K a year in hard savings at ~25K cases.

Challenges solved: Frees up coordination & rework spend. Speeds up safety & coding backlogs to alleviate trial delays.

WHO RUNS IT

Pharmacovigilance IT, safety data management, with the CIO and Chief AI Officer

Stage: Clinical

THE CHALLENGE

ICSR intake, narrative normalization and MedDRA/WHO-DD coding are manual and repetitive, creating pharmacovigilance backlogs that slow trials.

THE PLATFORM PATTERN

A governed safety data hub anchors every case, with ontology-driven, rules-based fact extraction to normalize narratives and pre-populate coding that is traceable, not black-box. Straight-through processing handles roughly 45% of cases; the rest are prepopulated for human review, with every coded field traceable for inspection and Health Authority (HA) response.

EXPECTED OUTCOMES

Reduces per-case pharmacovigilance vendor fees
Cuts rework time and manual quality control
Shortens safety cycle times
Delivers cleaner safety datasets earlier

automation

Cut late-stage TMF remediation by ~35% and reduce CRO change orders with always-on classification, tagging and completeness checks.

Challenges solved: Frees up coordination & rework spend. Speeds up safety & coding backlogs to alleviate trial delays.

WHO RUNS IT

Clinical systems & IT, TMF operations, data management, with the CIO

Stage: Clinical

THE CHALLENGE

TMF gaps drive late-stage remediation, CRO reconciliation and change orders and raise the risk of a difficult FDA or EMA inspection.

THE PLATFORM PATTERN

Semantic classification tags artifacts automatically into a single, governed TMF evidence hub aligned to DIA reference models across studies, CROs and geographies, producing on-demand, inspection-ready evidence packs with full who/what/when/why traceability.

EXPECTED OUTCOMES

Cuts late-stage TMF remediation by ~35%
Reduces CRO reconciliation and change orders by ~25%
Avoids remediation statements of work
Protects clinical teams from audit disruption

agentic ai

Run site startup, amendments and vendor work orders through one governed orchestrator that creates, routes, reconciles and audits every task.

Challenge solved: AI pilots reach production safely.

WHO RUNS IT

Clinical Operations leadership, Clinical IT, Chief AI Officer, enterprise architecture

Stage: Clinical

THE CHALLENGE

Site startup and amendment work, including Institutional Review Board (IRB)/Ethics Committee (EC) packets, country and site checklists and vendor work orders, requires high-variance coordination, and late deliverables drive CRO change orders, rush fees and vendor extensions.

THE PLATFORM PATTERN

The governed clinical content hub anchors the content; agentic RAG technology runs an Action Orchestrator tool that creates, routes, reconciles and audits the work, with human approval gates and platform-managed provenance for GxP safety. High-variance coordination becomes a controlled, repeatable process.

EXPECTED OUTCOMES

Fewer CRO change orders (~30%)
Less rush and rework spend (~25%)
Avoided vendor extension costs via faster cycles
More predictable study-activation timelines

03 Manufacturing Manufacturing & Technical Operations

Resilient operations

VP Manufacturing, Head of MS&T, Head of Supply Chain

You own schedule adherence, Current Good Manufacturing Practice (cGMP) compliance and scale-up. A batch-level digital thread accelerates deviation closure and batch release and makes tech transfer knowledge reusable.

Use Cases

automation common first project

Unify Manufacturing Execution System (MES), Laboratory Information Management System (LIMS), Quality Management System (QMS), Enterprise Resource Planning (ERP) and Standard Operating Procedure (SOP) evidence into one batch-level digital thread so deviations close faster and batches release sooner.

Challenge solved: Investigations & deviations occurring less.

WHO RUNS IT

Manufacturing IT/OT, MES & LIMS owners, quality systems, with the CIO

Stage: Manufacturing

THE CHALLENGE

Slow investigations, repeat deviations and delayed release absorb avoidable cost and extend work-in-process and finished-goods hold times.

THE PLATFORM PATTERN

A governed release evidence fabric unifies MES, LIMS, QMS, ERP, SOP and validation data into one traceable batch-level digital thread that assembles investigation and disposition evidence automatically, using explainable, rules-based fact extraction and controlled vocabularies. Batches release right the first time.

EXPECTED OUTCOMES

~$1.5M less scrap and rework via faster root cause
~$750K lower paid investigation labor
~$450K lower inventory carrying cost from faster release
Stronger inspection readiness with explainable traceability

automation

Stop repeating failed engineering and Process Performance Qualification (PPQ) runs by making prior process knowledge that’s locked in PDFs and validation packs reusable at the next site.

Challenges solved: Knowledge & evidence no longer scattered across documents. Investigations & deviations occurring less.

WHO RUNS IT

MS&T, Manufacturing Science IT, knowledge management, with the CIO

Stage: Manufacturing

THE CHALLENGE

Tech transfers fail because process knowledge is locked in PDFs, validation packs, deviations and tribal expertise, driving failed PPQ runs, yield loss and high Contract Development and Manufacturing Organization (CDMO) and consulting spend.

THE PLATFORM PATTERN

A Tech Transfer Knowledge Fabric means every transfer starts from known-good parameters, proven control strategies and documented failure modes. AI autogenerates a transfer-readiness package with validated parameter ranges, top historical failure modes with Corrective and Preventive Action (CAPA) outcomes, equipment equivalency mapping and audit-ready evidence.

EXPECTED OUTCOMES

~$1.2M avoided failed engineering/PPQ runs
~$400K ramp yield improvement
~$300K reduced external and CDMO spend
Stronger PPQ and validation traceability

agentic ai

Automate deviation triage, evidence assembly, impact assessment and CAPA drafts with QA control intact at every step.

Challenge solved: AI pilots reach production safely

WHO RUNS IT

Chief AI Officer, Manufacturing and Quality IT, automation engineering

Stage: Manufacturing

THE CHALLENGE

Deviation triage, evidence assembly, impact assessment and CAPA drafting take days of manual work, and late surprises mean costly batch holds.

THE PLATFORM PATTERN

The platform provides the governed digital evidence thread; agentic RAG retrieves, reasons and drafts with full citations across MES, LIMS, QMS, SOP and history. The agent refuses to answer when evidence is insufficient, cites approved sources only and logs every prompt and output. QA stays the approver of record.

EXPECTED OUTCOMES

~$650K labor reduction (~2 hrs saved per deviation)
~$170K working-capital gain from faster disposition
~$900K scrap and rework avoidance
~$150K fewer contractors

04 Quality Quality Assurance & Control (QA/QC)

Compliance by design

CQO, Head of QA, Head of QC, Quality Compliance

You own the QMS, batch disposition and inspection readiness. Closed-loop deviation intelligence and a quality copilot keep decisions explainable, with QA authority intact.

Use Cases

automation

Stop paying for the same deviation twice; closed-loop intelligence flags repeat root causes before they reach scrap, retest or a delayed release.

Challenge solved: Investigations & deviations occurring less.

WHO RUNS IT

Quality systems & IT, QMS owners, data engineering, with the CIO

Stage: Quality

THE CHALLENGE

Reactive investigations repeat the same root causes, driving scrap, retest and release delays. The expensive failure is repetition, not just closure.

THE PLATFORM PATTERN

Semantic models standardize deviation taxonomy and extract facts from SOPs and narratives; the governed system of record semantically links deviations, CAPAs, SOP clauses, batch records, LIMS data, training and supplier lots. Investigators instantly see prior similar cases, proven root causes and effective CAPAs, resulting in prevention, with explainable, GxP-safe lineage.

EXPECTED OUTCOMES

Reduces repeat deviations at the root cause
Cuts investigation effort and improves outcome quality
Lowers retest and scrap
Speeds up batch disposition

copilot

Give QC one connected view of methods, specs and results so avoidable retests, excess outsourcing and late releases stop draining the lab budget.

Challenges solved: Knowledge & evidence no longer scattered across documents. Investigations & deviations occurring less.

WHO RUNS IT

QC IT, LIMS owners, data integrity and quality systems, with the CIO

Stage: Quality

THE CHALLENGE

Fragmented methods, specs and results drive avoidable retests, excess outsourcing and batch-release delays, leading to inflating lab costs and raising expiry and expedite risk.

THE PLATFORM PATTERN

Semantic models normalize QC vocabulary and extract structured facts from methods and specs; governed results and documents live together for instant traceability. Role-based copilots help analysts execute the right method, help supervisors prevent out-of-trend drift and help QA autocomplete release packages, all on a governed single source of truth.

EXPECTED OUTCOMES

Reduces avoidable retests
Lowers external lab outsourcing
Speeds up batch disposition
Strengthens data integrity and audit posture

agentic ai

Assemble batch-release packets and inspection response packs automatically, planned, retrieved, validated and cited.

Challenges solved: Frees up coordination & rework spend. AI pilots reach production safely.

WHO RUNS IT

Chief AI Officer, Quality IT, QMS and LIMS owners

Stage: Quality

THE CHALLENGE

Batch-release packet assembly and inspection-response prep create days of QA hold time, manual rework and war-room scrambles before an audit.

THE PLATFORM PATTERN

The platform provides governed retrieval, ontology-driven consistency and traceable rules; an agentic layer executes plan to retrieve, verify and assemble with full lineage. The agent verifies completeness and version correctness and routes only gaps to humans, shifting QA from paperwork to decision-making in an exception-only workflow.

EXPECTED OUTCOMES

Faster batch disposition and lower carrying cost
Fewer expedites and premium-freight events
Lower QA/QC and inspection labor
Stronger compliance confidence

05 Regulatory Regulatory Affairs

Defensible submissions

Chief Regulatory Officer, VP Regulatory Affairs, Regulatory Ops & Intelligence

You own submissions, labeling and high-availability (HA) relationships. A governed content hub assembles Electronic Common Technical Document (eCTD)-ready dossiers, tracks change impact and drafts HA responses with citations.

Use Cases

automation common first project

Replace document hunting across Regulatory Information Management (RIM), Electronic Document Management System (EDMS) and SharePoint with a governed,eCTD-ready content hub that cuts submission cost and cycle time.

Challenges solved: Knowledge & evidence no longer scattered across documents. Speeds up safety & coding backlogs to alleviate trial delays.

WHO RUNS IT

Regulatory operations, Regulatory IT and RIM owners, data engineering, with the CIO

Stage: Regulatory

THE CHALLENGE

Manual document hunting across RIM, EDMS and SharePoint drives rework, vendor dependency and late-cycle fire drills before every submission.

THE PLATFORM PATTERN

The platform replaces the document hunt with a single regulatory content hub that is autoclassified, submission-ready with end-to-end lineage. Ontology-driven natural language processing (NLP) and fact extraction power automated eCTD assembly across Modules 1-5, approved-content reuse and faster HA query response.

EXPECTED OUTCOMES

Right-the-first-time submissions with full traceability
Lower vendor publishing and QC spend
Fewer internal FTE hours for assembly and queries
Faster, more consistent HA responses

automation

Automate post-approval change and labeling impact analysis across products, markets, dossiers and claims while removing the regulatory change tax.

Challenges solved: More efficiency and lower cost for submissions & approvals. Frees up coordination & rework spend.

WHO RUNS IT

Regulatory operations, labeling systems & IT, knowledge engineering, with the CIO

Stage: Regulatory

THE CHALLENGE

Post-approval change and labeling analysis across products, markets, dossiers and claims is manual, resulting in missed dependencies, late or incorrect variations, remediation and inspection risk.

THE PLATFORM PATTERN

A governed content hub anchors regulated content; validated knowledge models are applied to link product to process and material to claim to market authorization. AI traces dependencies automatically and assembles evidence-ready impact packs for each change, becoming a governed change-to-submission digital thread.

EXPECTED OUTCOMES

~$140K fewer regulatory hours per change
~$180K less labeling and translation rework
~$150K avoided remediation and CAPA events
Consistent, compliant global labeling

agentic ai

Answer health authorities faster with an agentic copilot that drafts responses, tracks commitments and translates regulatory intelligence.

Challenges solved: More efficiency and lower cost for submissions & approvals. AI pilots reach production safely

WHO RUNS IT

Chief AI Officer, Regulatory operations IT, enterprise architecture

Stage: Regulatory

THE CHALLENGE

Slow HA responses, rush publishing cycles and manual regulatory-intelligence translation create fire drills, late-cycle risk and vendor overages. This is a lack of execution capability, not a search problem.

THE PLATFORM PATTERN

The governed Regulatory Content Fabric plus agentic RAG technology forms an agentic execution layer for regulated workflows. The agent retrieves authoritative evidence with citations, drafts responses, assembles traceable evidence packs, manages change impact and routes approvals, achieving execution—not just an answer.

EXPECTED OUTCOMES

~$84K faster Limit of Quantification (LoQ)/Incident Response (IR) labor savings
~$270K fewer rush publishing fees and rework
~$60K avoided remediation and CAPA spend
A scalable agentic foundation across Regulatory Affairs (RA), Chemistry, Manufacturing and Controls (CMC), Quality and Labeling

06 Commercial Commercial & Market Access

Compliance growth

CCO, CMO, VP Sales, Head of Market Access & Reimbursement

You own launch, formulary access and revenue integrity. Reusable evidence objects build payer dossiers on demand, and contract intelligence stops rebate and chargeback leakage.

Use Cases

automation

Shift market access from document rebuilds to reusable, governed evidence objects that assemble payer dossiers on demand.

Challenges solved: Frees up coordination & rework spend. Protects revenue maintained in contracts & access.

WHO RUNS IT

Market Access operations, Commercial IT, content and Medical, Legal & Regulatory (MLR) systems, with the CIO

Stage: Commercial

THE CHALLENGE

Market access rebuilds payer dossiers from scratch every time, but it can be slow, costly and inconsistent across products, indications and geographies.

THE PLATFORM PATTERN

The platform standardizes payer-relevant claims into reusable, governed evidence objects and assembles dossiers automatically via a factory model with traceable provenance and approved language across MLR and Market Access.

EXPECTED OUTCOMES

~30% lower Health Economics and Outcomes Research (HEOR) and agency spend
~15 days faster readiness cycles
~$126K/year avoided rework from fewer MLR loops
Repeatable factory that scales across products and markets

automation

Turn rebate and chargeback contracts into machine-interpretable facts, then systematically validate every claim against them.

Challenges solved: Protects revenue maintained in contracts & access.

WHO RUNS IT

Commercial operations IT, contracts and global tax network (GTN) systems, data engineering, with the CIO

Stage: Commercial

THE CHALLENGE

Rebate and chargeback contract interpretation varies, driving overpayments, slow disputes and margin leakage across Market Access.

THE PLATFORM PATTERN

Semantic contract intelligence turns rebate and chargeback contracts into governed, machine-interpretable facts. AI validates execution and surfaces discrepancies with traceable evidence, protecting gross-to-net accuracy and strengthening dispute win rates.

EXPECTED OUTCOMES

~$625K – $1.25M overpayment reduction (25 – 50 bps)
~$1.0M chargeback dispute recovery uplift
~$210K reduced external services and manual labor
Improved gross-to-net accuracy without new headcount

agentic ai

Assemble payer submissions autonomously on a governed truth layer for ontology, extraction and provenance with human sign-off.

Solves: Protects revenue maintained in contracts & access. AI pilots reach production safely

WHO RUNS IT

Chief AI Officer, Commercial IT, Market Access operations

Stage: Commercial

THE CHALLENGE

Payer submission packs, objection responses and dispute packets are high-cost, time-sensitive manual work, requiring vendor assembly, internal search and stitching.

THE PLATFORM PATTERN

An agentic Market Access Copilot sits on the governed truth layer for ontology, extraction and provenance that autonomously assembles payer submission packs, drafts objection responses and prepares dispute packets, with every claim sourced, validated and citation-backed, as well as guardrails for regulated use.

EXPECTED OUTCOMES

~$470K vendor content assembly automation
~$180K contractor and temporary labor avoidance
~$400K dispute recovery uplift
Scalable agentic foundation across Commercial functions

Bring Us Your Bottleneck

Customers Have Reported 73% More Correct Answers, 40% Less Time Searching and Time to Value in As Few as Six Months.

Talk to a Life Sciences Specialist

Webinar

On-Demand

Unlocking Historical Knowledge to Discover Untapped Scientific Value

Watch now and learn how to unlock historical R&D knowledge to drive innovation

Watch Webinar

Built for the Inspection, Not the Demo

The Governance Your Reviewers Will Ask About

Part 11-Aligned Evidence

The governed context layer carries audit trails, granular access controls and provenance on Good Practice (GxP) content, supporting 21 CFR Part 11-aligned recordkeeping from ingestion to output.

Validation-First Deployment

A deployment approach consistent with FDA Computer Software Assurance guidance and the human-oversight obligations of the EU AI Act for high-risk uses.

Substantiated Citations or Silence

Agentic retrieval-augmented generation (RAG) returns answers with citations to governed sources and halts when the evidence runs out, instead of improvising.

Retrieval-Time Security

Document-level permissions are enforced when the AI retrieves. An agent never sees content its user could not open. No after-the-fact filtering.

Change-Controlled Rules

Decision rules stay business-readable, versioned and auditable so quality owns what AI may decide, and every rule change has a trail.

Customized Deployment

Hybrid and on-premises options keep sensitive clinical and compound data inside controlled environments while teams use AI capabilities.

Talk to a Specialist

Proof, Not Promises

What Life Science Teams Report in Production

Pharmaceutical Leader | R&D Search
Semantic RAG Transformed Enterprise Research Search
Content was often duplicated, outdated or inconsistently tagged, making it difficult to find trustworthy answers.
Company Spokesperson, before deploying the Progress Data Platform
Read the story
73%
More correct answers from the baseline semantic graph
41%
Less poor-quality answers, improving to −59% with refinement
85%
Relevance score; top-result clicks rose to 70%

Syngenta | Science R&D
Synapse: AI Search Across Decades of Research
R&D teams can find information they might not have known existed and avoid wasting valuable time searching for it.
Geraint Duck, Product Safety Lead, Syngenta
Read the story
40%
Less time spent searching for research data
Accelerated
R&D decisions with faster, better informed insights
Uncovered
research previously 'lost' in enterprise silos

Biotechnology Company | Governance
Autoclassification Across the Drug Development Pipeline
It’s great to see something move from a conversation in a conference to demonstrated value.
Corporate Ontologist
Read the story
Speed
Faster retrieval of pipeline information for knowledge workers
Accuracy
Valid SharePoint classification, meeting or exceeding targets
Unified
One model of products, development activity and stage

Info-Tech Emotional Footprint Report, January 2026

Progress Data Platform ranked #1 and named a Champion in Metadata Management.

See the report

Gartner Peer Insights^TM

See what your peers in pharma and life sciences think of the Progress Data Platform.

Read the Verified Reviews

ISG Buyers Guide for Data Platforms, March 2026

Progress named Exemplary.

See the Report

One Platform Pattern

How the Progress Data Platform Makes AI Defensible

A data catalog tells you where evidence lives. This platform does the evidence work by assembling, checking, citing and routing it under rules your quality organization owns. All 18 use cases run on one governed foundation, so each new use case costs less than the last and every output can be defended to a regulator.

Your Validated Systems – Connected, Not Replaced